View Older Stories
-
Human Genome (HGSI) volatility low into analyst meeting
-
Stocks with implied volatility movement; HGSI COP
-
Stocks with implied volatility below 30-day mean; HGSI C
-
Stocks with implied volatility below 30-day mean; BP HGSI C
-
Stocks with implied volatility below 30-day mean; BP HGSI
-
Stocks with implied volatility below 30-day mean; BP C HGSI
-
Human Genome (HGSI) March volatility elevated at 136 into FDA approval of BENLYSTA
-
Stocks with implied volatility movement; HGSI LO TIVO
-
Stocks with implied volatility movement; TIVO HGSI LO
-
Stocks with implied volatility movement; TIVO HGSI LO
-
Stocks with implied volatility movement; KWK HGSI LO
-
Human Genome (HGSI) March put volatility elevated into FDA decision for lupus drug Benlysta
-
Stocks with implied volatility movement; HGSI TIVO LO
-
Human Genome (HGSI) March put volatility elevated at 94 into Benlysta PDUFA
-
Stocks with implied volatility below index mean range; FDX HGSI UNH
-
Stocks with implied volatility below index mean range; LEN HGSI AA
-
Stocks with implied volatility below index mean range; OREX HGSI TLB
-
Stocks with implied volatility above mean; MELA GENZ HGSI
-
Stocks with implied volatility above mean; MELA GENZ HGSI
-
Stocks with implied volatility above mean; ARG GENZ HGSI
-
Human Genome (HGSI) volatility elevated into PDUFA
-
Stocks with implied volatility above mean; ARG GENZ HGSI
-
Stocks with implied volatility above mean; CSCO DNDN HGSI
-
Stocks with implied volatility above mean; GENZ DNDN HGSI
-
Stocks with implied volatility above mean; GENZ DNDN HGSI
-
Stocks with implied volatility above mean; AVNR BIOD HGSI
-
Stocks with implied volatility above mean; AVNR VVUS HGSI
-
Stocks with implied volatility above mean; VVUS DNDN HGSI
-
Stocks with implied volatility above mean; VVUS DNDN HGSI
-
Stocks with implied volatility above mean; HGSI VVUS AMLN
-
Human Genome (HGSI) volatility elevated into PDUFA
-
Stocks with implied volatility above mean; HGSI ABK DNDN
-
Stocks with implied volatility above mean; HGSI SIRI DNDN
-
Stocks with implied volatility above mean; DNDN HGSI FSLR
-
Stocks with implied volatility above mean; MMR HGSI FSLR
-
Stocks with implied volatility above mean; HGSI FSLR POT
-
Stocks with implied volatility above mean; HGSI PG POT
-
Stocks with implied volatility above mean; HGSI PG POT
-
Human Genome (HGSI) October volatility low at 36, January elevated at 81 into FDA review
-
Human Genome (HGSI) January volatility elevated at 75 into FDA review
-
Stocks with implied volatility below index mean range; PAR AIG HGSI
-
Human Genome (HGSI) January volatility at 84 into FDA review
-
Stocks with implied volatility below index mean range; HGSI AIG GENZ
-
Stocks with implied volatility below index mean range; HGSI AIG POT
-
Human Genome (HGSI) January volatility elevated at 84 into December review
-
Human Genome (HGSI) September volatility at 43, January at 76
-
Stocks with implied volatility below index mean range; HGSI ALU AIG
-
Stocks with implied volatility below index mean range; C AIG HGSI
-
Stocks with implied volatility below 30-day mean; UAUA HGSI SIRI
-
Stocks with implied volatility below index mean range; AGNC HGSI MNKD
